|
|
|
Volumn 36, Issue 4 SUPPL. 8, 1999, Pages 11-15
|
|
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DNA TOPOISOMERASE INHIBITOR;
DOXORUBICIN;
ETOPOSIDE;
FLUDARABINE;
IFOSFAMIDE;
MESNA;
MITOXANTRONE;
PACLITAXEL;
PREDNISOLONE;
TOPOTECAN;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
HUMAN;
LYMPHOMA;
MAJOR CLINICAL STUDY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
HUMANS;
LYMPHOMA, NON-HODGKIN;
PACLITAXEL;
SALVAGE THERAPY;
TOPOTECAN;
|
|
EID: 0033403735
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (30)
|
